"Our commitment is to maintain the highest standards of research integrity, sound science and open communication during the research process," is a statement in a recently published "Bill of Rights" by pharma giant Procter&Gamble. As Phil Baty notes in the THES (24.2.2006) the company was urged to this steps after some irregularities in recent publication processes. In one case academic researchers performed a study for the company but had not full access to the studies data for analysis.
The bill of rights also states that "research authors will define and control the content and direction of any publications resulting from their work" and will have "final authority" over all publication content, writes Baty. Company-sponsored "ghostwriters" will provide help with writing papers "only if requested".
The bill of rights also states that "research authors will define and control the content and direction of any publications resulting from their work" and will have "final authority" over all publication content, writes Baty. Company-sponsored "ghostwriters" will provide help with writing papers "only if requested".